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john.brameld@nottingham.ac.ukAbstractFat infiltration within muscle is one of a number of features of vitamin D deficiency, which
leads to a decline inmuscle functionality. The origin of this fat is unclear, but one possibility is
that it forms from myogenic precursor cells present in the muscle, which transdifferentiate
into mature adipocytes. The current study examined the effect of the active form of
vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), on the capacity of the C2C12 muscle cell
line to differentiate towards the myogenic and adipogenic lineages. Cells were cultured in
myogenic or adipogenic differentiation media containing increasing concentrations
(0, 10K13, 10K11, 10K9, 10K7 or 10K5 M) of 1,25(OH)2D3 for up to 6 days and markers of
muscle and fat development were measured. Mature myofibres were formed in both
adipogenic and myogenic media, but fat droplets were only observed in adipogenic media.
Relative to controls, low physiological concentrations (10K13 and 10K11 M) of 1,25(OH)2D3
increased fat droplet accumulation, whereas high physiological (10K9 M) and supraphysio-
logical concentrations (R10K7 M) inhibited fat accumulation. This increased accumulation
of fat with low physiological concentrations (10K13 and 10K11 M) was associated with a
sequential up-regulation of Pparg2 (Pparg) and Fabp4 mRNA, indicating formation of
adipocytes, whereas higher concentrations (R10K9 M) reduced all these effects, and the
highest concentration (10K5 M) appeared to have toxic effects. This is the first study to
demonstrate dose-dependent effects of 1,25(OH)2D3 on the transdifferentiation of muscle
cells into adipose cells. Low physiological concentrations (possibly mimicking a deficient
state) induced adipogenesis, whereas higher (physiological and supraphysiological)
concentrations attenuated this effect.Key Words
" myogenesis
" adipogenesis
" vitamin D
" transdifferentiationde
its u
m,Journal of Endocrinology
(2013) 217, 45–58IntroductionVitamin D (VitD) is a key nutrient for maintaining the
health of the musculoskeletal system, with VitD deficiency
leading to myopathy, classically characterised by hypo-
tonia, weakness and atrophy of skeletal muscle, and a
deterioration in physical capacity (Ceglia 2008). Muscle
biopsies from VitD-deficient adults demonstrate enlargedinterfibrillar spaces, fibrosis and loss of type II fibre
complement (Yoshikawa et al. 1979, Ceglia 2008). There
is also an increase in fat infiltration within the muscle
(Ceglia 2008, Oh et al. 2009, Tagliafico et al. 2010) and a
similar effect is observed in elderly individuals where the
progressive loss in muscle mass and strength seen at ther the terms of the Society for
nrestricted non-commercial use,
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217 :1 46onset of sarcopenia is associated with an increase in fat
deposition within the tissue (Ryall et al. 2008).
It is of major concern that VitD deficiency is
particularly prevalent amongst the elderly population, as
its effects on the musculoskeletal system compound the
degenerative effects of sarcopenia (Holick 2007). This can
have major consequences for their welfare, as the resultant
decline in basic muscle function leads to an increased risk
of falls and bone fractures. This deterioration in muscle
strength and functionality is thought to result from not
just the loss in muscle fibres but also a progressive
infiltration of fat within the tissue (Goodpaster et al.
2001, Ryall et al. 2008). This fat infiltration has been
shown to directly impact on muscle strength and
functionality and is a key independent risk factor for
metabolic diseases such as insulin resistance and diabetes
(Goodpaster et al. 2003, Zoico et al. 2010).
In the blood circulation, VitD is found in two main
forms – calcidiol or 25-hydroxyvitamin D (25(OH)D),
which is an inactive precursor form, and calcitriol or
1,25-dihydroxyvitamin D (1,25(OH)2D), which is the
active form. Blood concentrations of calcidiol range
between 30 and 50 nM (i.e. 3–5!10K8 M; McLeod &
Cooke 1989), whereas calcitriol is much lower, ranging
between w2 and 350 pM (i.e. 2!10K12–3.5!10K10 M;
Zittermann et al. 2009). The active form, calcitriol, is
formed when circulating 25(OH)D is hydroxylated by the
1a-hydroxylase enzyme (CYP27b1), present mainly in the
kidney, to form the active 1,25(OH)2D (Takeyama &
Kato 2011). Activation then enables 1,25(OH)2D3 to bind
to the VitD receptor (VDR), a type of nuclear receptor, and
thereby regulates transcription of a number of VitD target
genes, which is thought to be the principal mechanism of
action of VitD. Down-regulation of this response occurs
via activation of the 24-hydroxylase enzyme (CYP24a1),
which hydroxylates various forms of VitD at carbon 24
resulting in inactivation and targeting for excretion
(Holick 2007). De novo synthesis of components required
for calcium cycling, phospholipid metabolism and cell
proliferation/differentiation in muscle is thought to be
mediated by VDR-driven mechanisms operating at the
level of gene transcription (Drittanti et al. 1989, Ceglia
2008), thereby playing an important role in maintaining
muscle structure and functionality.
The effects of VitD deficiency are reversible, and
studies have shown that VitD supplementation increases
the relative number and size of type II fibres in aged
skeletal muscle, which can improve balance, increase
overall muscle strength and ultimately reduce the inci-
dence of falls (Bischoff et al. 2003, Harwood et al. 2004,http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-12-0234
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not known what effect VitD supplementation has on fat
infiltration within muscle. Indeed, the origin of these
adipose cells and the mechanism by which they mature
within muscle remains unclear. It may correspond to
aberrant transdifferentiation of myogenic precursor cells
into adipocytes resulting in the formation of fat within the
intermuscular space (Vettor et al. 2009). Certainly numer-
ous studies have demonstrated that myogenic precursor
cells retain the potential to transdifferentiate towards the
adipogenic lineage (Hu et al. 1995, Grimaldi et al. 1997,
Holst et al. 2003, Seale et al. 2008, Vettor et al. 2009).
Previous work has shown that VitD has potent effects on
both adipogenesis (Ishida et al. 1988, Sato & Hiragun 1988,
Lenoir et al. 1996, Blumberg et al. 2006, Kong & Li 2006,
Thomson et al. 2007, Zhuang et al. 2007) and myogenesis
(Capiati et al. 1999, Garcia et al. 2011). Most have used
physiologically relevant concentrations of 1,25(OH)2D3,
but some have tended to use high physiological or
supraphysiological concentrations. Importantly, it is not
known whether VitD affects the transdifferentiation of
myogenic precursor cells into adipocytes. In order to
address this question, the current study investigated the
effect of a broad range of concentrations of the active form
of VitD3 (1,25(OH)2D3) on the capacity of the murine
C2C12 muscle cell line to differentiate or transdifferenti-
ate towards the myogenic or adipogenic lineages respect-
ively. We included 1,25(OH)2D3 concentrations covering
the physiological range (10K13–10K9 M), as well as the
supraphysiological concentrations (10K7 and 10K5 M)
used previously in other cell culture studies (Blumberg
et al. 2006, Zhuang et al. 2007, Garcia et al. 2011).Materials and methods
Cell culture and reagents
C2C12 cells were cultured in six-well plates in
growth media consisting of DMEM (Sigma) supplemented
with 10% heat-inactivated fetal bovine serum (hi-FBS),
100 units/ml penicillin and 0.1 mg/ml streptomycin
and maintained at 37 8C under 5% CO2 until
70–80% confluent. This corresponded to day 0 of
differentiation, at which stage cells were switched to
either myogenic or adipogenic differentiation media and
incubated for up to 6 days at 37 8C under 5% CO2.
Myogenic differentiation media consisted of DMEM
containing 2% horse serum and antibiotics and was
changed every 2 days until the end of the experiment.
For induction of adipogenic differentiation, cells werePublished by Bioscientifica Ltd.
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217 :1 47cultured in DMEM containing 10% hi-FBS, antibiotics,
0.5 mM isobutylmethylxanthine, 1 mM dexamethasone,
850 nM insulin, 10 nM tri-iodothyronine (T3) and 1 mM
rosiglitazone (peroxisome proliferator activated receptor g
(PPARg) agonist) from days 0 to 2. This induction medium
was then replaced with DMEM containing 10% hi-FBS,
antibiotics, 850 nM insulin, 10 nM T3 and 1 mM rosiglita-
zone from day 2 onwards and changed every 2 days until
the end of the experiment. Both myogenic and adipogenic
differentiation media were supplemented with increasing
concentrations (0, 10K13, 10K11, 10K9, 10K7 or 10K5 M) of
1,25(OH)2D3 (Sigma), which was dissolved and diluted
in DMSO. All treatments (including control) contained
0.1% (v/v) DMSO.Oil Red-O and haematoxylin staining
Accumulation of lipid droplets was monitored by phase
contrast microscopy. After 6 days of exposure to myogenic
or adipogenic differentiation media, cells were stained
with Oil Red-O to identify lipid droplets and counter-
stained with haematoxylin to delineate nuclear and
myofibre structures. Briefly, media were removed and
cells were fixed in 3.7% formaldehyde at room tempera-
ture for 30 min. Cells were washed twice with pre-warmed
(to 37 8C) PBS and then with 60% isopropanol, before
staining with 0.3% Oil Red-O (Sigma) for 30 min at
room temperature. Cells were then washed once in
60% isopropanol and twice in tap water, before counter-
staining with Harris haematoxylin (Sigma) for 3 min, all at
room temperature. Excess stain was removed by washing
twice in distilled water and then another two times in
Scott’s tap water (0.24 M sodium bicarbonate and 0.03 M
magnesium sulphate). Images were captured using an
Olympus SZH10 microscope (Olympus, Southend-on-Sea,
UK) and analysed using Image Pro (version 5.1, Rockville,
MD, USA) for the quantification of Oil Red-O staining. The
Image Pro Software detected the Oil Red-O staining using a
fixed threshold and then calculated percentage area of
staining for each image. Five field of view images from
each of four replicate wells (i.e. 20 in total) were quantified
for each treatment.Quantitative real-time PCR analysis
At the required timepoints (days 0, 2, 4 and 6), total RNA
was extracted from C2C12 cells using a High Pure RNA
isolation kit (Roche), according to the manufacturer’s
protocol. Samples were then stored frozen (K80 8C) before
first-strand cDNA synthesis using random hexamerhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-12-0234
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Printed in Great Britainprimers, as described previously (Hemmings et al. 2009).
Quantitative PCR was performed in duplicate using SYBR1
Master mix (Roche), 384-well microplates and the
LightCycler LC480 (Roche) configured for SYBR green
detection, again as described previously (Tonge et al.
2010). The primers for each transcript were designed using
Primer Express (Applied Biosystems) and are shown in
Table 1. A standard curve was produced using serial
dilutions of a pool of cDNA made from all samples to
check the linearity and efficiency of the PCR for every
gene, while melt curve analysis was used to check whether
there was only a single product. Transcript abundance was
determined using the standard curve method as described
previously (Brown et al. 2012). Previous studies in this cell
line (Brown et al. 2012) had demonstrated that expression
of all the common ‘housekeeper’ genes changes during
differentiation; therefore, all data were normalised to total
first-strand cDNA content, measured using Oligreen, as
described previously (Brown et al. 2012).Creatine kinase, DNA and protein assays
At the required timepoint (day 4), C2C12 cells from each
well were scraped into 1 ml of cold (4 8C) tri-sodium citrate
buffer (0.05 M, pH 6.8) and sonicated on ice for 15 s using
a benchtop ultrasonicator (Soniprep 150; MSE, London,
(UK) Ltd.), being stored frozen (K80 8C) before analysis.
Creatine kinase (CK) activity (IU/well) was measured using
a CK assay kit (Thermo Scientific Cramlington, North-
umberland, UK), as described previously (Brown et al.
2012). Briefly, thawed samples were transferred on to a
96-well microtitre plate and 200 ml of reaction buffer was
added according to the manufacturer’s instructions.
Absorption at 340 nm was measured at 30 8C every 5 min
over a 30-min period. DNA content (mg/well) of the
thawed cell lysate was measured using a fluorescence
plate reader assay adapted from Rago et al. (Rago et al.
1990, Hurley et al. 2006). Protein content (mg/well) was
measured via the Lowry method (Lowry et al. 1951)
adapted for 96-well plate format. Usually, we normalise
the CK activity data to DNA content to account for
differences in numbers of cells in each well. However, in
this case, normalising the CK activity data to DNA resulted
in the differences in CK activity observed between media
types (myogenic vs adipogenic) being exaggerated due to
the obvious differences in DNA contents (i.e. numbers of
cells and their differing morphology), as there were clear
differences in the types of cells present. We therefore opted
to include the three measurements (CK activity, protein
and DNA) separately on a per well basis.Published by Bioscientifica Ltd.
Table 1 Mouse-specific Primer sequences used for quan-
titative real-time PCR analysis. Primer sequences for PPARg1,
PPARg2 and UCP1 were obtained from Kajimura et al. (2009)
Gene Primer sequence (5 0–3 0)
MyoD Forward: CGTGGCAGCGAGCACTAC
Reverse: TGTAATCCATCATGCCATCAGA
Creatine kinase Forward: GCACTGGCCGCAGCAT
Reverse: GAGGGTAGTACTTGCCCTTGAACTC
Myogenin Forward: CCCATGGTGCCCAGTGAA
Reverse: GCAGATTGTGGGCGTCTGTA
Myf5 Forward: CAGCCCCACCTCCAACTG
Reverse: GCAGCACATGCATTTGATACATC
Pparg1 Forward: TGAAAGAAGCGGTGAACCACTG
Reverse: TGGCATCTCTGTGTCAACCATG
Pparg2 Forward: GCATGGTGCCTTCGCTGA
Reverse: TGGCATCTCTGTGTCAACCATG
Fabp4 Forward: AAGTGGGAGTGGGCTTTGC
Reverse: TGGTGACCAAATCCCCATTT
AdipoQ Forward: GACACCAAAAGGGCTCAGGAT
Reverse: TGGGCAGGATTAAGAGGAACA
Leptin Forward: CAAGCAGTGCCTATCCAGAAAGT
Reverse: CAAGCAGTGCCTATCCAGAAAGT
Ucp1 Forward: ACTGCCACACCTCCAGTCATT
Reverse: CTTTGCCTCACTCAGGATTGG
Prdm16 Forward: GAAGGTGTCCAAACTGACAATGC
Reverse: CGTCACTTTTGGCTAGCTTCCT
Elovl3 Forward: ATGAATTTCTCACGCGGGTTA
Reverse: GCTTACCCAGTACTCCTCCAAAAA
Cidea Forward: CCAGAGTCACCTTCGACCTATACA
Reverse: CTCGTACATCGTGGCTTTGACA
C/ebpb Forward: AGCGGCTGCAGAAGAAGGT
Reverse: GGCAGCTGCTTGAACAAGTTC
Pgc1a Forward: TGCAGCGGTCTTAGCACTCA
Reverse: CATGAATTCTCGGTCTTAACAATGG
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Data were analysed by one- or two-way ANOVA for effects
of 1,25(OH)2D3 concentration, media type (myogenic or
adipogenic) and/or timepoint (as appropriate) using SPSS
Statistical Software (19th Edition, Portsmouth, Hampshire,
UK). Percentage area of Oil Red-O staining was analysed by
one-way ANOVA (1,25(OH)2D3 concentration only). CK
activities, DNA and protein contents were analysed by
two-way ANOVA (1,25(OH)2D3 concentration and media
type). All real-time qPCR data were analysed by two-way
ANOVA (1,25(OH)2D3 concentration and timepoint), with
the data from myogenic and adipogenic media being
analysed separately. A post-hoc Bonferroni’s test was used
when appropriate (i.e. no significant interactions). All
means are for either nZ3 (CK activity, protein and DNA
contents) or nZ4 (Oil Red-O staining and all mRNA
expression) replicates (i.e. wells) for each treatment and
media type at each timepoint. P!0.05 was considered
statistically significant.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-12-0234
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Printed in Great BritainResults
Effects of 1,25(OH)2D3 on myotube formation and lipid
accumulation
Myotube formation was clearly evident in control cells
after 6 days in either myogenic or adipogenic differen-
tiation media (Fig. 1A and G). Phase contrast images of
control cells showed extensive myotube formation by
day 4 in myogenic media, which did not appear to increase
any further on day 5 (data not shown). By contrast,
myotubes were still visibly forming throughout days 4 and
5 of differentiation in control cells in adipogenic media
(data not shown), suggesting that myogenic differen-
tiation was slightly delayed, but there appeared to be no
difference in myotube formation between myogenic and
adipogenic media on day 6 (Fig. 1A and G).
Positive Oil Red-O staining confirmed the presence of
lipid droplets in control cells grown for 6 days in
adipogenic media (Fig. 1G), but there was no Oil Red-O
staining of cells grown in myogenic media (either without
or with 1,25(OH)2D3) for the same length of time (Fig. 1A,
B, C, D, E and F). Similarly, phase contrast images taken at
earlier timepoints demonstrated the formation of lipid
droplets after 4 days, but only in cells cultured in
adipogenic media (data not shown).
Dose-dependent effects of 1,25(OH)2D3 supple-
mentation for 6 days were observed on myotube forma-
tion, with addition of supraphysiological concentrations
(10K7 and 10K5 M) appearing to inhibit myotube forma-
tion in both myogenic and adipogenic media (Fig. 1E, F, K
and L). Relative to the control cells grown for 6 days in
adipogenic media, supplementation with increasing
concentrations of 1,25(OH)2D3 induced a bimodal effect
on lipid droplet accumulation in cells cultured in
adipogenic media, as determined by percentage area of
Oil Red-O staining (Fig. 2). At the lowest physiological
concentration (10K13 M), 1,25(OH)2D3 significantly
increased lipid droplet accumulation compared with
controls (P!0.01 Bonferroni; Figs 1H and 2), whereas
the highest concentrations (10K9 M and above), corre-
sponding to high physiological and supraphysiological
concentrations, inhibited lipid droplet formation
(P!0.001 Bonferroni; Figs 1J, K, L and 2).Expression of gene markers of white adipocytes
As observed for lipid droplet formation (Fig. 1G, H, I, J, K
and L), C2C12 cells grown in adipogenic media demon-
strated induction of genes indicative of differentiation ofPublished by Bioscientifica Ltd.
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Figure 1
Dose-dependent effects of 1,25(OH)2D3 on accumulation of lipid droplets
in C2C12 cells cultured in myogenic (A, B, C, D, E and F) or adipogenic (G, H,
I, J, K and L) media. Representative images of C2C12 cells stained with Oil
Red-O (as indicated by white arrows) and counterstained with haema-
toxylin to indicate lipid droplet and nuclei/myofibre structures respectively.
Cells were cultured for 6 days in myogenic (A, B, C, D, E and F) or adipogenic
(G, H, I, J, K and L) media with vehicle (A and G) or increasing
concentrations of 1,25(OH)2D3 (10
K13 M (B and H), 10K11 M (C and I),
10K9 M (D and J), 10K7 M (E and K) or 10K5 M (F and L)).
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include figures for the expression of genes in adipogenic
media, but the figures showing expression of these same
genes by cells cultured in myogenic media are included in
the Supplementary Figure 1A, B, C and D, see section on
supplementary data given at the end of this article. In
adipogenic media, expression of all three adipose-specific
marker genes, Pparg2 (Pparg; Fig. 3A), fatty acid binding
protein 4 (Fabp4; Fig. 3B) and adiponectin/Adipoq
(Fig. 3C), were induced in a 1,25(OH)2D3 concentration
and time-dependent manner (P!0.001 for all three
1,25(OH)2D3 concentration!day interactions), but only
in cells grown in adipogenic media. Low physiological
concentrations (10K13 and 10K11 M) of 1,25(OH)2D3
increased expression of all three genes, with levels of
PPARg2 peaking at day 2 and declining over days 4 and 6
(Fig. 3A), while expression of the PPARg2 target genes,
Fabp4 and Adipoq, peaked 2 days later at day 4 of
differentiation (Fig. 3B and C). Interestingly, the high
physiological (10K9 M) and supraphysiological (10K7 and
10K5 M) concentrations of 1,25(OH)2D3 decreased
expression of all three genes, corresponding to the
observed decrease in lipid droplet formation. By contrast,
expression of these genes by cells incubated in myogenic
media was either undetectable (PPARg2; Supplementary
Figure 1A) or only expressed in the presence of supra-
physiological concentrations of 1,25(OH)2D3 (FABP4 and
ADIPOQ; Supplementary Figure 1B and C). Leptin mRNA
was not detectable in any of the cultures (in adipogenic or
myogenic media) throughout the 6-day period (data not
shown). In contrast to PPARg2, which is known to be
adipocyte specific, Pparg1 mRNA was detected in all
cultures (in both myogenic and adipogenic media) and
was found to be higher at day 2 than at day 6 (PZ0.002 for
day effect; Fig. 3D) in adipogenic media and higher in
controls and 10K5 M 1,25(OH)2D3 than the other concen-
trations (PZ0.005 for 1,25(OH)2D3 concentration effect;
Fig. 3D) again in adipogenic media.Effects of 1,25(OH)2D3 on myogenic differentiation in
myogenic and adipogenic media
It was apparent from the morphological studies that
supplementation with supraphysiological concentrations
(10K7 and 10K5 M) of 1,25(OH)2D3 inhibited myotube
formation in both myogenic and adipogenic media
(Fig. 1E, F, K and L). We therefore determined CK activities
after 4 days of treatment, as a quantitative measure of
myogenic differentiation. Lower CK activities were
observed for control cells in adipogenic compared withPublished by Bioscientifica Ltd.
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Figure 2
Dose-dependent effects of 1,25(OH)2D3 on percentage area of lipid
accumulation in C2C12 cells cultured in adipogenic media for 6 days. C2C12
cells were stained with Oil Red-O and counterstained with haematoxylin,
before the percentage area of the red stain within a field of view (FOV) was
quantified by image analysis to give a representative percentage area per
well (nZ4 wells, five FOV/well). One-way ANOVA indicated a significant
effect of 1,25(OH)2D3 (P!0.001). Significant differences compared to
DMSO control cells were determined by post-hoc Bonferroni’s test
(**P!0.01 and ***P!0.001).
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adipogenic media with 1,25(OH)2D3 increased CK activity
to levels approaching those observed in control cells in
myogenic media and the magnitude of this increase was
similar between 10K13 and 10K7 M (P!0.001 for media
!1,25(OH)2D3 concentration interaction; Fig. 4A).
By contrast, cells exposed to 10K5 M 1,25(OH)2D3 in adi-
pogenic media showed a decrease in CK activity compared
with controls (P!0.001 for media!1,25(OH)2D3 concen-
tration interaction; Fig. 4A), indicating an attenuation of
myogenic differentiation, consistent with the observed
absence of myotubes in these cultures (Fig. 1L). In
myogenic media, addition of 1,25(OH)2D3 at 10
K7 and
10K5 M was also associated with a reduction in CK activity
(P!0.001 for media!1,25(OH)2D3 concentration
interaction; Fig. 4A), as well as reductions in total protein
(P!0.01 for media!1,25(OH)2D3 concentration inter-
action; Fig. 4B) and total DNA (P!0.001 for media!
1,25(OH)2D3 concentration interaction; Fig. 4C) contents
at day 4. Protein (Fig. 4B) and DNA (Fig. 4C) contents were
greater in cells cultured in adipogenic compared with
myogenic media, indicative of increased cell proliferation,
probably due to the higher FBS content of the adipo-
genic media. Similar to effects in myogenic media,
increasing 1,25(OH)2D3 concentrations in adipogenichttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-12-0234
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Printed in Great Britainmedia decreased both protein (P!0.01 for media!
1,25(OH)2D3 concentration interaction; Fig. 4B) and
DNA (P!0.001 for media!1,25(OH)2D3 concentration
interaction; Fig. 4C) contents in a dose-dependent
manner, but particularly at the highest (supraphysiolo-
gical) concentrations.Expression of myogenic marker genes
Consistent with myotube formation being observed in
both types of differentiation media (Fig. 1A, B, C, D, E, F, G
and H), muscle-specific genes were expressed in cells
grown in either myogenic or adipogenic media. For clarity,
we will mainly describe the results from studies using
adipogenic media here, but figures for expression of
the same genes by cells cultured in myogenic media are
included in the Supplementary Figure 1E, F, G and H. The
effects of 1,25(OH)2D3 (particularly physiological concen-
trations) on myogenic marker genes were more pro-
nounced in adipogenic media (Fig. 5A, B, C and D)
compared with myogenic media (Supplementary Figure 1E,
F, G and H), consistent with the results obtained for CK
activity. Similar to CK activity, CK mRNA expression was
lower in adipogenic media compared with myogenic
media (Fig. 5A and Supplementary Figure 1E). An increase
in CK mRNA was observed at day 4 in control cells (in
adipogenic media), but supplementation of adipogenic
media with physiological concentrations (10K13, 10K11
and 10K9 M) of 1,25(OH)2D3 increased CK mRNA
expression particularly on day 4, whereas 10K5 M
1,25(OH)2D3 blocked/inhibited differentiation at all time-
points (P!0.001 for 1,25(OH)2D3 concentration!day
interaction; Fig. 5A). A similar pattern was observed for
myogenin expression (Fig. 5B). Adipogenic media induced
a smaller increase in myogenin mRNA on day 2 compared
with myogenic media (Fig. 5B and Supplementary Figure 1F),
but myogenin mRNA continued to increase on days 4 and 6
in adipogenic media and actually exceeded the levels
observed in myogenic media (Fig. 5B and Supplementary
Figure 1F). Supplementation of adipogenic media with
10K13, 10K11, 10K9 or 10K7 M 1,25(OH)2D3 increased
myogenin mRNA, particularly on day 2, whereas 10K5 M
1,25(OH)2D3 blocked differentiation at all timepoints
(P!0.001 for 1,25(OH)2D3 concentration!day inter-
action; Fig. 5B). In adipogenic media, there was no
change in Myod1 (MyoD) expression in control cells
throughout the 6 days of differentiation (Fig. 5C), but
supplementation with 10K13, 10K11, 10K9 or 10K7 M
1,25(OH)2D3 increased MyoD on days 2 and 4, whereas
10K5 M 1,25(OH)2D3 blocked these effects (PZ0.001 forPublished by Bioscientifica Ltd.
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Figure 3
Dose-dependent effects of 1,25(OH)2D3 on expression of white adipocyte
marker genes. Expression of white adipocyte marker genes was determined
by quantitative RT-PCR analysis. Levels of (A) Pparg2, (B) Fabp4,
(C) Adipoq/adiponectin and (D) Pparg1 mRNAs were quantified in C2C12
cells cultured in the absence or presence of 10K13, 10K11, 10K9, 10K7 or
10K5 M 1,25(OH)2D3 for 2, 4 or 6 days in adipogenic differentiation media.
Expression at day 0 (before differentiation media and 1,25(OH)2D3 was
added) is also included and is indicated by a bar (in some instances, this was
very low). Significant two-way interactions between day of differentiation
and 1,25(OH)2D3 concentration were observed for PPARg2, FABP4 and
AdipoQ (P!0.001 for all). For PPARg1, there was a significant effect of
stage of differentiation (PZ0.002) and a significant effect of 1,25(OH)2D3
concentration (PZ0.005), but no interaction.
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Finally, myf5 mRNA was up-regulated in control cells in
adipogenic media at days 2 and 4 (Fig. 5D), but this was
inhibited by increasing concentrations of 1,25(OH)2D3 in
a dose-dependent manner, with 10K5 M 1,25(OH)2D3
appearing to block differentiation (P!0.001 for
1,25(OH)2D3 concentration!day interaction; Fig. 5D).
In summary, there were only relatively small effects of
1,25(OH)2D3 on cells incubated in myogenic media (see
Supplementary Figure 1E, F, G and H), mainly due to the
effects of the highest (supraphysiological) concentration
(10K5 M). However, supplementation of adipogenic media
with physiological (10K13, 10K11 and 10K9 M) concentra-
tions of 1,25(OH)2D3 increased CK, MyoD and myogenin
mRNA, suggesting an induction of muscle differentiation.
Importantly, 10K5 M 1,25(OH)2D3 blocked/inhibited
expression of all four myogenic marker genes in adipo-
genic media, suggesting that this concentration (10K5 M)
may have a different effect to the other concentrations,
possibly involving anti-differentiation, pro-apoptotic
and/or toxic effects.Expression of gene markers of brown adipocytes
As 1,25(OH)2D3 was shown to induce gene markers of
white adipocytes, we also considered its effect on
activation of genes relating to brown adipocytes. Once
again, for clarity, only the data from studies in adipogenic
media are included, but data for myogenic media are
provided in the Supplementary Figure 2A, B, C and D, see
section on supplementary data given at the end of this
article. Expression of the brown fat-specific marker,
uncoupling protein 1 (UCP1), was below detectable levels
in cells grown in either myogenic or adipogenic media
(data not shown). Likewise, expression of PRD1-BF1-RIZ1
homologous domain containing 16 (Prdm16), previously
shown to be required for the transdifferentiation of C2C12
cells to brown adipocytes (Seale et al. 2008), was also below
detectable limits (data not shown). However, expression of
other brown fat marker genes, Elovl3 and CIDEA, were
detectable in cells cultured in adipogenic media, but only
after 6 days (P!0.001 for day effect for both genes; Fig. 6A
and B respectively). This was preceded by a slight decrease
in the expression of CCAAT enhancer binding protein b
(C/ebpb) mRNA (P!0.001 for day effect; Fig. 6C) at
days 2–6, but no change in expression of PPARg
coactivator 1a (PGC1a; Fig. 6D) mRNA. In contrast
to the changes observed in expression of the white
adipogenic marker genes, treatment with 1,25(OH)2D3
had no significant effect (PO0.05) on expression of any ofPublished by Bioscientifica Ltd.
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Figure 4
Dose-dependent effects of 1,25(OH)2D3 on (A) CK activity (IU/well),
(B) protein (mg/well) and (C) DNA content (mg/well) in C2C12 cells cultured
for 4 days in myogenic media (MM) or adipogenic media (AM) with
increasing concentrations (vehicle control, 10K13, 10K11, 10K9, 10K7 and
10K5 M) of 1,25(OH)2D3. Significant two-way interactions between media
type and 1,25(OH)2D3 concentration were observed for CK activity
(P!0.001), protein (P!0.01) and DNA (P!0.001) content.
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Printed in Great Britainthe brown adipocyte marker genes, suggesting that
1,25(OH)2D3 treatment was not inducing conversion of
myoblasts to brown adipocytes, although a longer time
frame may be required to be completely sure.Expression of VDR and the VitD hydroxylating enzymes
1a-hydroxylase and 24-hydroxylase
As the activity of the VitD system is dependent on the levels
of VDR and metabolising enzymes, we also determined
their expression in the cell cultures. Once again, for clarity,
the data from adipogenic media will mainly be described
here, but the data from myogenic media are provided in the
Supplementary Figure 2E, F and G. VDR mRNA was
expressed in the C2C12 cells and there was no difference
in the level of expression between control cells incubated
in either myogenic or adipogenic media (Fig. 7A and
Supplementary Figure 2E). In adipogenic media, VDR
expression was increased by the highest concentration
(10K5 M) of 1,25(OH)2D3 particularly on day 2 (P!0.001
for VitD concentration!day interaction; Fig. 7A). Basal
levels of expression of the 25(OH)D3 activating enzyme,
CYP27B1 (1a-hydroxylase) mRNA, increased in control
cells incubated in adipogenic media throughout the 6 days
of differentiation (P!0.001 for day effect; Fig. 7B), but there
was no significant effect of 1,25(OH)2D3 on CYP27B1
mRNA expression (PO0.05; Fig. 7B).
In contrast to the activating enzyme, expression of
the VitD inactivating enzyme, CYP24a1 (also called
24-hydroxylase), was not detectable in control cells
incubated in adipogenic media and did not change with
day/stage of differentiation (Fig. 7C), but treatment with
10K5 M 1,25(OH)2D3 induced CYP24A1 mRNA expression
(P!0.001 for 1,25(OH)2D3 concentration effect; Fig. 7C).
Hence, the cells appear to be responding to the very high
levels of active VitD by increasing the levels of this
inactivating enzyme to avoid or minimise potential
toxicity effects.Discussion
Adipogenic induction
For the first time, this study shows a bimodal
dose–response effect of the active form of VitD3,
1,25(OH)2D3, to modulate the capacity of C2C12 cells to
transdifferentiate into adipocytes. The adipogenic
potential of C2C12 cells has been shown previously,
with exposure to thiazolidinediones and fatty acids
found to induce transdifferentiation to mature adipocytesPublished by Bioscientifica Ltd.
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Figure 5
Dose-dependent effects of 1,25(OH)2D3 on expression of skeletal muscle
marker genes. Expression of skeletal muscle marker genes was determined
by quantitative RT-PCR analysis. Levels of (A) CK, (B) myogenin, (C) MyoD
and (D)Myf5mRNAs were quantified in C2C12 cells cultured in the absence
or presence of 10K13, 10K11, 10K9, 10K7 or 10K5 M 1,25(OH)2D3 for 2, 4 or 6
days in adipogenic differentiation media. Expression at day 0 (before
differentiation media and 1,25(OH)2D3 was added) is also included for
reference and is indicated by a bar. Significant two-way interactions
between day of differentiation and 1,25(OH)2D3 concentration were
observed for CK, myogenin, Myf5 (P!0.001 for all) and MyoD (P!0.05)
mRNA transcripts.
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Printed in Great Britain(Teboul et al. 1995). A key finding from these studies was
that physiologically relevant, sub-nanomolar (10K13 M)
concentrations of 1,25(OH)2D3 potently induced accumu-
lation of lipid droplets in adipogenic media. Importantly,
this was preceded by a clear up-regulation in expression of
the adipogenic marker genes, PPARg2 and FABP4, which
were undetectable in cells grown in myogenic media.
PPARg2 has previously been shown to be pivotal in
inducing the transdifferentiation of myogenic precursor
cells to the adipogenic lineage (Hu et al. 1995, Yu et al.
2006). This study showed that expression of Pparg2
mRNA peaked on day 2 of differentiation followed by a
sequential up-regulation in expression of downstream
target genes, Fabp4 and Adipoq, both of which peaked at
day 4 in adipogenic media. Interestingly, decreases in lipid
accumulation (Oil Red-O percentage area) and adipocyte
marker gene expression (Pparg2 and Fabp4) were
observed at higher physiological concentrations
(between 10K13 and 10K9 M) of 1,25(OH)2D3 without
any change in DNA or protein contents, whereas
supraphysiological concentrations (10K7 and 10K5 M)
of 1,25(OH)2D3 completely inhibited lipid droplet
accumulation and decreased expression of adipogenic
marker genes but also reduced DNA and protein
contents. Hence, the mechanisms for the anti-differen-
tiation effects of the highest concentrations are potentially
due to anti-proliferative and/or pro-apoptotic/toxic
effects, but this appears not to be the case for the
lower, more physiological concentrations. Therefore,
the bimodal effects of 1,25(OH)2D3 in altering the
transdifferentiation to an adipogenic lineage occurred
over a physiologically relevant concentration range and
appeared not to be due to anti-proliferative or toxic
effects, suggesting that our findings may be indicative of
effects in vivo.
Previous studies have reported similar bimodal effects
of 1,25(OH)2D3 over similar concentration ranges on
adipogenesis in 3T3-L1 (Thomson et al. 2007) and Ob17
preadipocytes (Lenoir et al. 1996). Consistent with our
findings, Lenoir et al. (1996) showed that 1,25(OH)2D3
stimulated adipogenesis at concentrations of 0.25 nM
(2.5!10K10 M) or less, whereas nanomolar concen-
trations almost completely blocked adipogenic differ-
entiation. Similarly, 0.1 nM (10K10 M) 1,25(OH)2D3
stimulated adipogenesis, whereas 1 and 10 nM (10K9 and
10K8 M) inhibited adipogenesis in 3T3-L1 preadipocytes
(Thomson et al. 2007). Inhibitory effects of high nano-
molar concentrations (1–100 nM or 10K9–10K7 M) of
1,25(OH)2D3 on adipogenesis have also been reported in
3T3-L1 preadipocytes (Blumberg et al. 2006, Kong & LiPublished by Bioscientifica Ltd.
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Figure 6
Dose-dependent effects of 1,25(OH)2D3 on expression of brown adipocyte
marker genes. Expression of brown adipocyte marker genes was
determined by quantitative RT-PCR analysis. Levels of (A) Elovl3, (B) Cidea,
(C) C/ebpb and (D) Pgc1amRNAs were quantified in C2C12 cells cultured in
the absence or presence of 10K13, 10K11, 10K9, 10K7 or 10K5 M 1,25(OH)2D3
for 2, 4 or 6 days in adipogenic differentiation media. Expression at day 0
(before differentiation media and 1,25(OH)2D3 was added) is also included
for reference and is indicated by a bar. Significant effects of day of
differentiation were observed for Elovl3, Cidea and C/ebpb (P!0.001 for all
three), but not PGC1a (PO0.05). There were no significant effects of
1,25(OH)2D3 concentration on any of the brown adipocyte marker genes.
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decreases in C/ebpa and Pparg2 mRNA expression
(Blumberg et al. 2006, Kong & Li 2006, Thomson et al.
2007). Interestingly, 3T3-L1 preadipocytes were only
receptive to this inhibitory effect in the early stages of
differentiation (i.e. the induction phase), with no effect
observed when 1,25(OH)2D3 was administered from
48 h onwards (Kong & Li 2006). This receptive period in
3T3-L1 cells may relate to temporal changes in VDR
expression, which is rapidly up-regulated in preadipocytes
in the first 4–8 h of differentiation and then progressively
down-regulated in the following 48 h (Kong & Li 2006).
We observed something similar, with higher VDR
expression at day 2 compared with days 4 and 6 in
adipogenic media. Interestingly, only the highest supra-
physiological (10K5 M) concentration of 1,25(OH)2D3
increased expression of VDR, particularly at day 2 of
differentiation in adipogenic media.
Having established that C2C12 cells appeared to be
induced to transdifferentiate into adipocytes, a number of
brown fat-specific marker genes were also measured to
clarify whether the cells being formed were white or
brown adipocytes. Recent findings from lineage tracing
studies have shown that brown adipocytes develop in vivo
from a MYF5-positive progenitor cell (Seale et al. 2008),
suggesting that these myf5-expressing C2C12 cells might
also be converting to brown adipocytes. Previous work
showed that ectopic overexpression of PRDM16 in C2C12
cells induced Myf5 gene expression and this was
associated with diversion of these cells to the brown fat
lineage (Seale et al. 2008). In this study, Myf5 mRNA
expression in C2C12 cells was up-regulated in adipogenic
media compared with myogenic media at all timepoints
over the 6-day culture period, but Prdm16 mRNA was
expressed at very low levels in all cultures, below the
threshold at which expression could be accurately
quantified (data not shown). Similarly, Ucp1 expression
was not detectable in these cultures (data not shown).
Other brown adipocyte-specific marker genes, Elovl3 and
Cidea, were activated in cells cultured in adipogenic
media, but not until day 6 of differentiation, and the
expression was a lot more variable, as indicated by the
larger error bars. This suggests that activation of brown
adipogenic genes may be occurring, but at a much later
stage in the developmental process, for which further
investigation is required. However, the absence of any
effect of 1,25(OH)2D3 treatment on any of the brown fat
genes measured suggests that the dose-dependent changes
in lipid accumulation observed relate to white rather than
brown adipogenesis.Published by Bioscientifica Ltd.
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Figure 7
Dose-dependent effects of 1,25(OH)2D3 on expression of VDR, CYP27B1
(1a-hydroxylase) and CYP24A1 (24-hydroxylase) enzymes. Expression of
VitD-related genes was determined by quantitative RT-PCR analysis. Levels
of (A) Vdr, (B) Cyp27b1 and (C) Cyp24a1 mRNAs were quantified in C2C12
cells cultured in the absence or presence of 10K13, 10K11, 10K9, 10K7 or
10K5 M 1,25(OH)2D3 for 2, 4 or 6 days in adipogenic differentiation media.
Expression at day 0 (before differentiation media and 1,25(OH)2D3 was
added) is also included for reference and is indicated by a bar. A significant
two-way interaction (P!0.001) between day of differentiation and
1,25(OH)2D3 concentration was observed for VDR only. There was a
significant effect of day of differentiation (PZ0.001) on expression of
Cyp27b1 mRNA, but no effect of 1,25(OH)2D3 concentration. By contrast,
there was a significant effect (P!0.001) of 1,25(OH)2D3 concentration on
Cyp24a1 mRNA, but no effect of day of differentiation.
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Our results show that exposure to adipogenic media
induces C2C12 cells to transdifferentiate into cells that
accumulate lipid droplets and thus resemble a mature
adipocyte. This indicates some degree of plasticity in the
lineage potential of this ‘muscle cell line’, but it should be
noted that extensive myotube formation was still evident,
even in the presence of adipogenic media. Previous studies
whereby C2C12 cells were induced to form adipocytes
following exposure to thiazolidinediones and fatty acids
indicated that this transdifferentiation to mature adipo-
cytes was associated with an inhibition of myogenic
differentiation (Teboul et al. 1995). An initial myogenesis
inhibitory effect of exposing C2C12 cells to adipogenic
media was evident in our studies, as CK activity was
reduced in control cells exposed to adipogenic compared
with myogenic media. This was associated with delayed
activation of myogenesis, as indicated by reduced myo-
genin and Ck mRNA at day 2 and was possibly a
consequence of increased cell proliferation, as indicated
by the increase in DNA content observed, presumably due
to the higher FBS content of the adipogenic media.
However, this study indicated that the three physiological
concentrations (10K13–10K9 M) of 1,25(OH)2D3 appeared
to induce myogenesis (in adipogenic media only), rather
than inhibit it. Indeed, the low physiological (10K13 M)
concentration of 1,25(OH)2D3 appeared to increase both
adipogenesis and myogenesis, whereas the high physio-
logical (10K9 M) concentration only increased myogenesis
and the highest supraphysiological (10K5 M) concen-
tration inhibited both. This is consistent with previous
work in which a high physiological concentration
(10K9 M) of 1,25(OH)2D3 was shown to increase fusion/
differentiation of chick embryo myoblasts during late
stages of myogenesis (Capiati et al. 1999).Local regulation of activity
Circulating levels of 1,25(OH)2D3 are tightly regulated by
the activity of the hydroxylating enzymes, 1a-hydroxyl-
ase (CYP27b1) and 24-hydroxylase (CYP24a1). In this
study, the activating enzyme, Cyp27b1 mRNA, was found
to be expressed by C2C12 cells and expression increased
with day/stage of differentiation in adipogenic media, but
there was no effect of 1,25(OH)2D3. Although the highest
concentration (10K5 M) appeared to reduce expression of
Cyp27b1 mRNA, this was not statistically significant.
Previous work (Turunen et al. 2007) has shown that
1,25(OH)2D3 administered at suprananomolar levelsPublished by Bioscientifica Ltd.
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activity in HEK 293 cells. It should be noted that there
was no detectable expression in the C2C12 cells of the
inactivating enzyme, CYP24a1 (24-hydroxylase), apart
from when 1,25(OH)2D3 was supplemented at levels in
excess of the physiological range (10K7–10K5 M), when
an induction was observed. This likely occurs as a
mechanism to protect the cells from toxic effects of
such high non-physiological levels of the active vitamin.
Similarly, VDR mRNA was very low (but detectable)
and induced at the highest (10K5 M) concentration.
This would appear to suggest that there were toxic
effects of the highest concentration(s) of 1,25(OH)2D3,
but that this was not the case for the other, more
physiological concentrations (10K13–10K9 M), indicating
that their effects on morphology and gene expression
are unlikely to be via anti-proliferative/pro-apoptotic
mechanisms.Physiological relevance
It is difficult to extrapolate from this study to the likely
effects of VitD deficiency on the level of transdifferentia-
tion of muscle precursor cells to adipocytes that occur in
muscle in vivo. Our findings suggest that low (deficient)
levels (Zittermann et al. 2009) of 1,25(OH)2D3
(i.e. 10K13 M) may actually enhance adipogenic transdif-
ferentiation, whereas high (sufficient) levels (i.e. 10K9 M)
inhibit adipogenesis, thereby potentially impacting on fat
infiltration and muscle function. A number of studies have
demonstrated the ability of primary muscle cells to form
adipocytes, but the mechanisms involved are not clear
(Asakura et al. 2001, Csete et al. 2001, Aguiari et al. 2008).
However, the C2C12 cell model is likely to be a
conservative model of adipogenic transdifferentiation, as
primary satellite cells isolated from pig muscle demon-
strate a much higher degree of plasticity with a greater
number of adipocytes and a lower number of myotubes
formed in response to adipogenic media (Redshaw et al.
2010). The exposure of myogenic precursor cells to
adipogenic regulatory factors may be an important factor
in contributing to the increased fat infiltration seen in
muscle, for example during ageing and VitD deficiency,
although infiltration by already committed adipocyte
populations is also possible. VitD has been shown to
play a key regulatory role in myogenesis and is likely to be
important in muscle fibre repair (Capiati et al. 1999, Garcia
et al. 2011).
A speculative interpretation of the bimodal response
of C2C12 cells to 1,25(OH)2D3 observed in vitro is that ithttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-12-0234
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Printed in Great Britainrepresents an energy-conserving mechanism in vivo that
has evolved in response to the changing seasons and
enables extra energy to be repartitioned into fat depots.
Certainly for our ancestors, a significant quantity of VitD
was primarily obtained from exposure to u.v./sunlight,
which induces the conversion of 7-dehydrocholesterol to
VitD3. Low levels of VitD in the body, which possibly
occur during periods of low u.v. exposure such as winter
(Moosgaard et al. 2005, Aguiari et al. 2008), may act as an
important regulatory cue in inducing muscle precursor
cells to form adipocytes rather than myofibres and enable
extra fat depots to be stored in the body during periods of
austerity. This speculative hypothesis needs testing in an
appropriate animal model.
In conclusion, this is the first study to show that
low physiological concentrations (0.1–10 pM or
10K13–10K11 M) of 1,25(OH)2D3, which may represent a
VitD-deficient state, induce myoblasts to transdifferentiate
into the adipogenic lineage and appears to involve
activation of PPARg2. These findings have implications
for muscle health and function as well as whole-body
energy metabolism because an increase in fat infiltration
within skeletal muscle has been linked with a decrease in
functional strength and impairment of glucose tolerance,
leading to an increased susceptibility to obesity and type II
diabetes (Goodpaster et al. 2003, Hilton et al. 2008). High
concentrations (1 nM or 10K9 M and above) of
1,25(OH)2D3 appeared to block adipogenic transdifferen-
tiation, suggesting that changes in physiological concen-
trations of 1,25(OH)2D3 have a major impact on the
determination of cell fate of myogenic precursor cells.
Furthermore, our data indicate that levels of 1,25(OH)2D3
in the serum and muscle are likely to be important
biomarkers linking VitD intakes and optimal muscular
health. Given the widespread prevalence of VitD defici-
ency, particularly in the elderly population, understand-
ing the role of this vitamin in muscle differentiation
processes throughout life will be key to defining
nutritional parameters for maintaining life-long health
and well-being.Supplementary data
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